114 related articles for article (PubMed ID: 6834840)
21. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.
Grogan M; Thomas GM; Melamed I; Wong FL; Pearcey RG; Joseph PK; Portelance L; Crook J; Jones KD
Cancer; 1999 Oct; 86(8):1528-36. PubMed ID: 10526282
[TBL] [Abstract][Full Text] [Related]
22. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
23. Interstitial irradiation in the management of recurrent carcinoma of the cervix after previous radiation therapy.
Randall ME; Barrett RJ
N C Med J; 1988 Jun; 49(6):306-8. PubMed ID: 3135500
[No Abstract] [Full Text] [Related]
24. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066
[No Abstract] [Full Text] [Related]
25. [Treatment of pelvic recurrences of carcinoma of the cervix uteri by radiotherapy alone].
Bignardi M; Bardelli D; Bertoni F; Tordiglione M
Radiol Med; 1988 May; 75(5):540-4. PubMed ID: 3375497
[TBL] [Abstract][Full Text] [Related]
26. Prognosis, recurrences and metastases correlated to histologic cell type in carcinoma of the uterine cervix.
Johansson O; Johnsson JE; Lindberg JG; Sydsjö A
Acta Obstet Gynecol Scand; 1976; 55(3):255-9. PubMed ID: 936990
[TBL] [Abstract][Full Text] [Related]
27. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
[TBL] [Abstract][Full Text] [Related]
28. Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: Results of a prospective randomized phase III trial.
Sharma M; Revannasiddaiah S; Gupta M; Seam RK; Gupta MK; Rastogi M
J Cancer Res Ther; 2016; 12(1):103-8. PubMed ID: 27072219
[TBL] [Abstract][Full Text] [Related]
29. [Apropos of 25 cases of endocurietherapy in epitheliomas of the uterine cervix and of the vagina (recurrences or in advanced stage)].
Chassagne D; Pierquin B
Minerva Med; 1967 Dec; 58(99):4534-5. PubMed ID: 6082436
[No Abstract] [Full Text] [Related]
30. Serum lactic dehydrogenase isoenzymes alteration in carcinoma cervix uteri.
Kumar M; Birdi A; Gupta YN; Gupta S
Int J Gynaecol Obstet; 1988 Aug; 27(1):91-5. PubMed ID: 2905306
[TBL] [Abstract][Full Text] [Related]
31. Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging.
Ohara K; Tanaka Y; Tsunoda H; Nishida M; Sugahara S; Itai Y
Obstet Gynecol; 2002 Oct; 100(4):781-7. PubMed ID: 12383549
[TBL] [Abstract][Full Text] [Related]
32. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix.
Dickson J; Davidson SE; Hunter RD; West CM
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):991-5. PubMed ID: 11072155
[TBL] [Abstract][Full Text] [Related]
34. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
35. Serum copper and zinc levels in patients with nasopharyngeal carcinoma.
Lian SL; Hsu HY; Lin SM
Taiwan Yi Xue Hui Za Zhi; 1989 Mar; 88(3):236-9. PubMed ID: 2794920
[TBL] [Abstract][Full Text] [Related]
36. The use of glycogen studies in the evaluation of treatment for carcinoma of the cervix uteri.
Das DK; Chowdury JR
Acta Cytol; 1981; 25(5):566-71. PubMed ID: 6945022
[TBL] [Abstract][Full Text] [Related]
37. High energy therapy for recurrences of carcinoma of the cervix uteri.
Nieminen U; Kotsalo K
Ann Chir Gynaecol Fenn; 1966; 55(4):313-6. PubMed ID: 4961078
[No Abstract] [Full Text] [Related]
38. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
40. Plasma histaminase activity in carcinoma of the cervix--its clinical significance.
Birdi A; Gupta S; Gambhir SS
J Surg Oncol; 1984 Apr; 25(4):296-9. PubMed ID: 6425564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
